Evotec SE (OTCMKTS:EVTCY – Get Free Report) reached a new 52-week low on Wednesday . The company traded as low as $3.09 and last traded at $3.10, with a volume of 105186 shares. The stock had previously closed at $3.20.
Evotec Stock Performance
The stock has a market cap of $1.02 billion, a PE ratio of 7.80 and a beta of 0.98. The stock has a fifty day simple moving average of $4.41 and a two-hundred day simple moving average of $5.78. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Stories
- Five stocks we like better than Evotec
- 5 discounted opportunities for dividend growth investors
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- Find and Profitably Trade Stocks at 52-Week Lows
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
